This company is delisted or no longer publicly traded. The analysis below is archived and will not be updated.

Exact Sciences Corporation EXAS

Updated: 5 Sep 2026

NASDAQ | Biotech | Cancer diagnostics
Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Cancer diagnostics
We're already tracking Exact Sciences Corporation — here are the latest events we've registered

Recent News

  • On March 23, 2026, Abbott Laboratories completed its acquisition of Exact Sciences in a transaction valued at approximately $21 billion, or $105 per share. The transaction provided Exact Sciences stockholders with cash consideration and resulted in the company being delisted from NASDAQ. The merger integrates Exact Sciences' cancer screening platforms into Abbott's diagnostics division.

What Firelda Watch includes for Exact Sciences Corporation

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Exact Sciences Corporation will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.